Exhausting T cells in CLL

Blood

Volumn 121, Issue 9, 2013, Pages 1485-1486

  Zenz, Thorsten ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; CD8+ T LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CYTOKINE PRODUCTION; HUMAN; INFECTION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY; T LYMPHOCYTE EXHAUSTION;

EID: 84876494033     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-01-475939     Document Type: Short Survey

References (10)

1. Riches JC, Davies JK, McClanahan F, et al.Tcells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production. Blood. 2013;121(9): 1612-1621.
2. Wherry EJ.Tcell exhaustion. Nat Immunol. 2011;12(6): 492-499.
3. Doering TA, Crawford A, Angelosanto JM, Paley MA, Ziegler CG, Wherry EJ. Network analysis reveals centrally connected genes and pathways involved in CD8(-)Tcell exhaustion versus memory. Immunity. 2012;37(6):1130-1144.
4. Brahmer JR, Tykodi SS, Chow LQ, et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.NEngl J Med. 2012;366(26):2455-2465.
5. Topalian SL, Hodi FS, Brahmer JR, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. NEngl J Med. 2012;366(26):2443-2454.
6. Ramsay AG, Johnson AJ, Lee AM, et al. Chronic lymphocytic leukemiaTcells show impaired immunological synapse formation that can be reversed with an immunomodulating drug. J Clin Invest. 2008;118(7):2427-2437. (Pubitemid 351949771)
7. Duhren-von Minden M, Ubelhart R, Schneider D, et al. Chronic lymphocytic leukaemia is driven by antigenindependent cell-autonomous signalling. Nature. 2012; 489(7415):309-312.
8. Paley MA, Kroy DC, Odorizzi PM, et al. Progenitor and terminal subsets of CD8+Tcells cooperate to contain chronic viral infection. Science. 2012;338(6111):1220-1225.
9. Moreno C, Hodgson K, Ferrer G, et al. Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance. Blood. 2010;116(23):4771-4776.
10. Zenz T, Ritgen M, Dreger P, et al. Autologous graftversus-host disease-like syndrome after an alemtuzumabcontaining conditioning regimen and autologous stem cell transplantation for chronic lymphocytic leukemia. Blood. 2006;108(6):2127-2130. (Pubitemid 44395031)